Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'COA REDUCTASE INHIBITOR' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 284 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Best, JD; Jenkins, AJ
      Novel agents for managing dyslipidaemia

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    2. Holdaas, H; Fellstrom, B; Holme, I; Nyberg, G; Fauchald, P; Jardine, A; Gronhagen-Riska, C; Madser, S; Neumayer, HH; Cole, E; Maes, B; Weinreich, T; Olsson, AG; Pedersen, TR; Benghozi, R; Hartmann, A
      Effects of fluvastatin on cardiac events in renal transplant patients: ALERT (Assessment of Lescol (R) in Renal Transplantation) study design and baseline data

      JOURNAL OF CARDIOVASCULAR RISK
    3. Fernandez, JC; Mas, R; Catano, G; Menendez, R; Amor, AM; Gonzalez, RM; Alvarez, E
      Comparison of the efficacy, safety and tolerability of policosanol versus fluvastatin in elderly hypercholesterolaemic women

      CLINICAL DRUG INVESTIGATION
    4. Dostal, LA; Juneau, P; Rothwell, CE
      Repeated analysis of semen parameters in beagle dogs during a 2-year studywith the HMG-CoA reductase inhibitor, atorvastatin

      TOXICOLOGICAL SCIENCES
    5. Yoshida, M; Sawada, T; Ishii, H; Gerszten, RE; Rosenzweig, A; Gimbrone, MA; Yasukochi, Y; Numano, F
      HMG-CoA reductase inhibitor modulates monocyte-endothelial cell interaction under physiological flow conditions in vitro - Involvement of Rho GTPase-dependent mechanism

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    6. Wong, WWL; Tan, MM; Xia, ZL; Dimitroulakos, J; Minden, MD; Penn, LZ
      Cerivastatin triggers tumor-specific apoptosis with higher efficacy than lovastatin

      CLINICAL CANCER RESEARCH
    7. Imaeda, A; Aoki, T; Kondo, Y; Hori, M; Ogata, M; Obayashi, H; Hasegawa, G; Nakamura, N; Tokuda, K; Nishino, H; Yoshikawa, T; Kondo, M
      Protective effects of fluvastatin against reactive oxygen species induced DNA damage and mutagenesis

      FREE RADICAL RESEARCH
    8. Murakami, M; Goto, T; Saito, Y; Goto, S; Kochi, M; Ushio, Y
      The inhibitory effect of simvastatin on growth in malignant gliomas - withspecial reference to its local application with fibrin glue spray in vivo

      INTERNATIONAL JOURNAL OF ONCOLOGY
    9. Wierzbicki, AS
      Lipid-lowering drugs in lupus: an unexplored therapeutic intervention

      LUPUS
    10. Koh, KK; Son, IW; Ahn, JY; Choi, YM; Jin, DK; Park, GS; Choi, IS; Sohn, MS; Shin, EK
      Non-lipid effects of statin on hypercholesterolemic patients established to have coronary artery disease who remained hypercholesterolemic while eating a step-II diet

      CORONARY ARTERY DISEASE
    11. Khong, TK; Missouris, CG; Belli, AM; MacGregor, GA
      Regression of atherosclerotic renal artery stenosis with aggressive lipid lowering therapy

      JOURNAL OF HUMAN HYPERTENSION
    12. Muck, W; Park, S; Jager, W; Voith, B; Wandel, E; Galle, PR; Schwarting, A
      The pharmacokinetics of cerivastatin in patients on chronic hemodialysis

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    13. Harder, S; Mohr, O; Klepzig, H
      Lipid-lowering treatment in coronary artery disease: a survey in an ambulatory outpatient clinic

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    14. Aoki, S; Ikeda, K; Yamamura, M; Kojo, S
      Protective effect of fluvastatin on degradation of apolipoprotein B by a radical reaction in human plasma

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    15. Kawabata, H; Ryomoto, T; Ishikawa, K
      Role of cardiac ATP-sensitive K+ channels induced by HMG CoA reductase inhibitor in ischemic rabbit hearts

      Hypertension research
    16. Sahu, KM; Sharma, RK; Gupta, A; Gulati, S; Agarwal, DK; Kumar, A; Bhandari, M
      Effect of lovastatin, an HMG CoA reductase inhibitor, on acute renal allograft rejection

      CLINICAL TRANSPLANTATION
    17. Stein, EA
      Aggressive treatment of dyslipidemia: A review of supporting evidence

      CLEVELAND CLINIC JOURNAL OF MEDICINE
    18. Lau, TK; Leachman, DR; Lufschanowski, R
      Severe rhabdomyolysis associated with the cerivastatin-gemfibrozil combination therapy - Report of a case

      TEXAS HEART INSTITUTE JOURNAL
    19. Ishigam, M; Uchiyama, M; Kondo, T; Iwabuchi, H; Inoue, S; Takasaki, W; Ikeda, T; Komai, T; Ito, K; Sugiyama, Y
      Inhibition of in vitro metabolism of simvastatin by itraconazole in humansand prediction of in vivo drug-drug interactions

      PHARMACEUTICAL RESEARCH
    20. Chen, H; Xing, Y; Liu, RH
      Lovastatin increases nitric oxide synthesis in IL-I beta- stimulated smooth muscle cells

      CHINESE MEDICAL JOURNAL
    21. Katoh, M; Kurosawa, Y; Tanaka, K; Watanabe, A; Doi, H; Narita, H
      Fluvastatin inhibits O-2(-) and ICAM-1 levels in a rat model with aortic remodeling induced by pressure overload

      AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
    22. Joukhadar, C; Klein, N; Prinz, M; Schrolnberger, C; Vukovich, T; Wolz, M; Schmetterer, L; Dorner, GT
      Similar effects of atorvastatin, simvastatin and pravastatin on thrombogenic and inflammatory parameters in patients with hypercholesterolemia

      THROMBOSIS AND HAEMOSTASIS
    23. Carazo, A; Alejandere, MJ; Louktibi, A; Linares, A
      The reversal of the inhibition on lipids synthesis by L-659,699 in arterial smooth muscle cells cultures

      MOLECULAR AND CELLULAR BIOCHEMISTRY
    24. Breuer, HWM
      Hypertriglyceridemia: A review of clinical relevance and treatment options: Focus on cerivastatin

      CURRENT MEDICAL RESEARCH AND OPINION
    25. Goudevenos, JA; Bairaktari, ET; Chatzidimou, KG; Milionis, HJ; Mikhailidis, DP; Elisaf, MS
      The effect of atorvastatin on serum lipids, lipoprotein(a) and plasma fibrinogen levels in primary dyslipidaemia - A pilot study involving serial sampling

      CURRENT MEDICAL RESEARCH AND OPINION
    26. Malyszko, J; Malyszko, JS; Hryszko, T; Mysliwiec, M
      Effects of long-term treatment with simvastatin on some hemostatic parameters in continuous ambulatory peritoneal dialysis patients

      AMERICAN JOURNAL OF NEPHROLOGY
    27. Borrego, FJ; Liebana, A; Borrego, J; del Barrio, PP; Gil, JM; Cortes, MJG; Perales, CS; Serrano, P; Banasco, VP
      Rhabdomyolysis and acute renal failure associated with pravastatin and simvastatin

      NEFROLOGIA
    28. Isaacsohn, J; Insull, W; Stein, E; Kwiterovich, P; Ma, P; Brazg, R; Dujovne, CA; Shan, M; Shugrue-Crowley, E; Ripa, S; Tota, R
      Long-term efficacy and safety of cerivastatin 0.8 mg in patients with primary hypercholesterolemia

      CLINICAL CARDIOLOGY
    29. McPherson, R; Hanna, K; Agro, A; Braeken, A
      Cerivastatin versus branded pravastatin in the treatment of primary hypercholesterolemia in primary care practice in Canada: A one-year, open-label, randomized, comparative study of efficacy, safety, and cost-effectiveness

      CLINICAL THERAPEUTICS
    30. El-Sankary, W; Gibson, GG; Ayrton, A; Plant, N
      Use of a reporter gene assay to predict and rank the potency and efficacy of CYP3A4 inducers

      DRUG METABOLISM AND DISPOSITION
    31. Moriyama, T; Kawada, N; Nagatoya, K; Takeji, M; Horio, M; Ando, A; Imai, E; Hori, M
      Fluvastatin suppresses oxidative stress and fibrosis in the interstitium of mouse kidneys with unilateral ureteral obstruction

      KIDNEY INTERNATIONAL
    32. Hausberg, M; Kosch, M; Stam, F; Heidenreich, S; Kisters, K; Rahn, KH; Barenbrock, M
      Effect of fluvastatin on endothelium-dependent brachial artery vasodilation in patients after renal transplantation

      KIDNEY INTERNATIONAL
    33. Susekov, AV
      Validation of elevation of statins doses in clinical practice

      TERAPEVTICHESKII ARKHIV
    34. Marcus, AO
      Lipid disorders in patients with type 2 diabetes - Meeting the challenges of early, aggressive treatment

      POSTGRADUATE MEDICINE
    35. Igel, M; Sudhop, T; vonBergmann, K
      Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A-reductase inhibitors (statins)

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    36. Isaacsohn, J; Zinny, M; Mazzu, A; Lettieri, J; Heller, AH
      Influence of gender on the pharmacokinetics, safety, and tolerability of cerivastatin in healthy adults

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    37. Nakashima, A; Ohtawa, M; Masuda, N; Morikawa, H; Iwasaki, K
      Antioxidative effects of fluvastatin, and its major metabolites [II]

      YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN
    38. Nakashima, A; Ohtawa, M; Iwasaki, K; Wada, M; Kuroda, N; Nakashima, K
      Inhibitory effects of fluvastain and its metabolites on the formation of several reactive oxygen species

      LIFE SCIENCES
    39. Joyce, M; Kelly, C; Winter, D; Chen, G; Leahy, A; Bouchier-Hayes, D
      Pravastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, attenuates renal injury in an experimental model of ischemia-reperfusion

      JOURNAL OF SURGICAL RESEARCH
    40. Nakai, D; Nakagomi, R; Furuta, Y; Tokui, T; Abe, T; Ikeda, T; Nishimura, K
      Human liver-specific organic anion transporter, LST-1, mediates uptake of pravastatin by human hepatocytes

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    41. Kaneider, NC; Reinisch, CM; Dunzendorfer, S; Meierhofer, C; Djanani, A; Wiedermann, CJ
      Induction of apoptosis and inhibition of migration of inflammatory and vascular wall cells by cerivastatin

      ATHEROSCLEROSIS
    42. Pedro-Botet, J; Schaefer, EJ; Bakker-Arkema, RG; Black, DM; Stein, EM; Corella, D; Ordovas, JM
      Apolipoprotein E genotype affects plasma lipid response to atorvastatin ina gender specific manner

      ATHEROSCLEROSIS
    43. Funatsu, T; Suzuki, K; Goto, M; Arai, Y; Kakuta, H; Tanaka, H; Yasuda, S; Ida, M; Nishijima, S; Miyata, K
      Prolonged inhibition of cholesterol synthesis by atorvastatin inhibits apoB-100 and triglyceride secretion from HepG2 cells

      ATHEROSCLEROSIS
    44. Sumi, D; Hayashi, T; Thakur, NK; Jayachandran, M; Asai, Y; Kano, H; Matsui, H; Iguchi, A
      A HMG-CoA reductase inhibitor possesses a potent anti-atherosclerotic effect other than serum lipid lowering effects - the relevance of endothelial nitric oxide synthase and superoxide anion scavenging action

      ATHEROSCLEROSIS
    45. Rosenson, RS; Tangney, CC; Schaefer, EJ
      Comparative study of HMG-CoA reductase inhibitors on fibrinogen

      ATHEROSCLEROSIS
    46. Morishita, E; Asakura, H; Saito, M; Yamazaki, M; Ontachi, Y; Mizutani, T; Kato, M; Matsuda, T; Nakao, S
      Elevated plasma levels of free-form of TFPI antigen in hypercholesterolemic patients

      ATHEROSCLEROSIS
    47. Vincent, L; Chen, W; Hong, L; Mirshahi, F; Mishal, Z; Mirshahi-Khorassani, T; Vannier, JP; Soria, J; Soria, C
      Inhibition of endothelial cell migration by cerivastatin, an HMG-CoA reductase inhibitor: contribution to its anti-angiogenic effect

      FEBS LETTERS
    48. Gnad, R; Kaina, B; Fritz, G
      Rho GTPases are involved in the regulation of NF-kappa B by genotoxic stress

      EXPERIMENTAL CELL RESEARCH
    49. Miller, SJ
      Emerging mechanisms for secondary cardioprotective effects of statins

      CARDIOVASCULAR RESEARCH
    50. Kawata, S; Yamasaki, E; Nagase, T; Inui, Y; Ito, N; Matsuda, Y; Inada, M; Tamura, S; Noda, S; Imai, Y; Matsuzawa, Y
      Effect of pravastatin on survival in patients with advanced hepatocellularcarcinoma. A randomized controlled trial

      BRITISH JOURNAL OF CANCER
    51. Aoki, T; Yamazaki, H; Suzuki, H; Tamaki, T; Sato, F; Kitahara, M; Saito, Y
      Cholesterol-lowering effect of NK-104, a 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, in guinea pig model of hyperlipidemia

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    52. Suzuki, H; Yamazaki, H; Aoki, T; Tamaki, T; Sato, F; Kitahara, M; Saito, Y
      Hypolipidemic effect of NK-104 and other 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in guinea pigs

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    53. McKenney, JM; McCormick, LS; Schaefer, EJ; Black, DM; Watkins, ML
      Effect of niacin and atorvastatin on lipoprotein subclasses in patients with atherogenic dyslipidemia

      AMERICAN JOURNAL OF CARDIOLOGY
    54. Thompson, GR; Naoumova, RP
      Novel lipid-regulating drugs

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    55. Kajinami, K; Mabuchi, H; Saito, Y
      NK-104: a novel synthetic HMG-CoA reductase inhibitor

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    56. van Dam, M; Basart, DCG; Janus, C; Zwertbroek, R; Spierenburg, HAM; Werner, HA; Bredero, AC; Lansberg, PJ; Jonker, CJ; Trip, MD; Prins, MH; Kastelein, JJP
      Additional efficacy of milligram-equivalent doses of atorvastatin over simvastatin

      CLINICAL DRUG INVESTIGATION
    57. Wagner, AH; Kohler, T; Ruckschloss, U; Just, I; Hecker, M
      Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    58. Hong, R; Sequeira, W
      Rhabdomyolysis in a patient taking simvastatin after addition of cyclosporine therapy

      JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
    59. Pauletto, P; Puato, M; Faggin, E; Sartore, S
      Low-dose cerivastatin inhibits spontaneous atherogenesis in heterozygous Watanabe hyperlipidemic rabbits

      JOURNAL OF VASCULAR RESEARCH
    60. Siekmeier, R; Gross, W; Marz, W
      Determination of pravastatin by high performance liquid chromatography

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    61. Muck, W; Frey, R; Unger, S; Voith, B
      Pharmacokinetics of cerivastatin when administered under fasted and fed conditions in the morning or evening

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    62. Romero, R; Calvino, J; Rodriguez, J; Sanchez-Guisande, D
      Short-term effect of atorvastatin in hypercholesterolaemic renal-transplant patients unresponsive to other statins

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    63. Hufnagel, G; Michel, C; Vrtovsnik, F; Queffeulou, G; Kossari, N; Mignon, F
      Effects of atorvastatin on dyslipidaemia in uraemic patients on peritonealdialysis

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    64. Moriyama, T; Kawada, N; Nagatoya, K; Horio, M; Imai, E; Hori, M
      Oxidative stress in tubulointerstitial injury: therapeutic potential of antioxidants towards interstitial fibrosis

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    65. Suzumura, K; Tanaka, K; Yasuhara, M; Narita, H
      Inhibitory effects of fluvastatin and its metabolites on hydrogen peroxide-induced oxidative destruction of hemin and low-density lipoprotein

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    66. Egashira, K; Ni, WH; Inoue, S; Kataoka, C; Kitamoto, S; Koyanagi, M; Takeshita, A
      Pravastatin attenuates cardiovascular inflammatory and proliferative changes in a rat model of chronic inhibition of nitric oxide synthesis by its cholesterol-lowering independent actions

      Hypertension research
    67. Mulvana, D; Jemal, M; Pulver, SC
      Quantitative determination of pravastatin and its biotransformation products in human serum by turbo ion spray LC/MS/MS

      JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    68. Jemal, M; Xia, YQ
      Bioanalytical method validation design for the simultaneous quantitation of analytes that may undergo interconversion during analysis

      JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    69. Marz, W; Wieland, H
      HMG-CoA reductase inhibition: Anti-inflammatory effects beyond lipid lowering?

      HERZ
    70. Ganne, F; Vasse, M; Beaudeux, JL; Peynet, J; Francois, A; Mishal, Z; Chartier, A; Tobelem, G; Vannier, JP; Soria, J; Soria, C
      Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits urokinase/urokinase-receptor expression and MMP-9 secretion by peripheral blood monocytes -A possible protective mechanism against atherothrombosis

      THROMBOSIS AND HAEMOSTASIS
    71. Kagota, S; Yamaguchi, Y; Nakamura, K; Kunitomo, M
      Functional evidence for anti-oxidant action of fluvastatin on low-density lipoprotein using isolated macrophages and aorta

      CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
    72. Travert, C; Fofana, M; Carreau, S; Le Goff, D
      Rat Leydig cells use apolipoprotein E depleted high density lipoprotein toregulate testosterone production

      MOLECULAR AND CELLULAR BIOCHEMISTRY
    73. Insull, W; Isaacsohn, J; Kwiterovich, P; Ma, P; Brazg, R; Dujovne, C; Shan, M; Shugrue-Crowley, E; Ripa, S; Tota, R
      Efficacy and safety of cerivastatin 0.8 mg in patients with hypercholesterolaemia: the pivotal placebo-controlled clinical trial

      JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
    74. Yamada, M; Huang, ZH; Dalkara, T; Endres, M; Laufs, U; Waeber, C; Huang, PL; Liao, JK; Moskowitz, MA
      Endothelial nitric oxide synthase-dependent cerebral blood flow augmentation by L-arginine after chronic statin treatment

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    75. Kim, SI; Kim, HJ; Han, DC; Lee, HB
      Effect of lovastatin on small GTP binding proteins and on TGF-beta 1 and fibronectin expression

      KIDNEY INTERNATIONAL
    76. Hosokawa, R; Nohara, R; Li, LX; Tamaki, S; Hashimoto, T; Tanaka, M; Miki, S; Sasayama, S
      Effect of long-term cholesterol-lowering treatment with HMG-CoA reductase inhibitor (simvastatin) on myocardial perfusion evaluated by thallium-201 single photon emission computed tomography

      JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION
    77. Bouzbouz, S; Cossy, J
      Enantioselective allyltitanation. Application to the synthesis of lactone units related to compactin and mevinolin

      TETRAHEDRON LETTERS
    78. Noseda, G; Darioli, R; Keller, U; Mordasini, R; Shokry, A; Schaffhauser, B; Riesen, W
      Efficacy and tolerance of atorvastatin in hyperlipidaemia in private practice

      SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT
    79. Mazzu, AL; Lettieri, JT; Kelly, E; Vargas, R; Marbury, T; Liu, MC; Sundaresan, P
      Influence of renal function on the pharmacokinetics of cerivastatin in normocholesterolemic adults

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    80. Saunders, E; Ferdinand, K; Yellen, LG; Tonkon, MJ; Krug-Gourley, S; Poland, M
      Efficacy and safety of cerivastatin and pravastatin in the treatment of primary hypercholesterolemia

      JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION
    81. Inoue, I; Goto, S; Mizotani, K; Awata, T; Mastunaga, T; Kawai, S; Nakajima, T; Hokari, S; Komoda, T; Katayama, S
      Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect - Reduction of MRNA levels for interleukin-1 beta, interleukin-6, cyclooxygenase-2, and p22phox by regulation of peroxisome proliferator-activated receptor alpha (PPAR alpha) in primary endothelial cells

      LIFE SCIENCES
    82. Akhmedzhanov, NM; Deyanda, DM; Perova, NV; Oganov, RG
      Lipid lowering activity of cerivastatin in patients with ischemic heart disease

      KARDIOLOGIYA
    83. Karki, SB; Treemaneekarn, V; Kaufman, MJ
      Oxidation of HMG-CoA reductase inhibitors by tert-butoxyl and 1,1-diphenyl-2-picrylhydrazyl radicals: Model reactions for predicting oxidatively sensitive compounds during preformulation

      JOURNAL OF PHARMACEUTICAL SCIENCES
    84. Isusi, E; Aspichueta, P; Liza, M; Hernandez, ML; Diaz, C; Hernandez, G; Martinez, MJ; Ochoa, B
      Short- and long-term effects of atorvastatin, lovastatin and simvastatin on the cellular metabolism of cholesteryl esters and VLDL secretion in rat hepatocytes

      ATHEROSCLEROSIS
    85. Yamamoto, A; Harada-Shiba, M; Kawaguchi, A; Oi, K; Kubo, H; Sakai, S; Mikami, Y; Imai, T; Ito, T; Kato, H; Endo, M; Sato, I; Suzuki, Y; Hori, H
      The effect of atorvastatin on serum lipids and lipoproteins in patients with homozyous familial hypercholesterolemia undergoing LDL-apheresis therapy

      ATHEROSCLEROSIS
    86. Schmaldienst, S; Banyai, S; Stulnig, TM; Heinz, G; Jansen, M; Horl, WH; Derfler, K
      Prospective randomised cross-over comparison of three LDL-apheresis systems in statin pretreated patients with familial hypercholesterolaemia

      ATHEROSCLEROSIS
    87. Bakker-Arkema, RG; Nawrocki, JW; Black, DM
      Safety profile of atrovastatin-treated patients with low LDL-cholesterol levels

      ATHEROSCLEROSIS
    88. Houghton, JL; Pearson, TA; Reed, RG; Torosoff, MT; Henches, NL; Kuhner, PA; Philbin, EF
      Cholesterol lowering with pravastatin improves resistance artery endothelial function - Report of six subjects with normal coronary arteriograms

      CHEST
    89. Nguyen, G; Cruickshank, J; Mouillard, A; Dumuis, ML; Picard, C; Cailleteau, X; Pantou, X; Dupuis, R; Portal, JJ; Maigret, P
      Comparison of achievement of treatment targets as perceived by physicians and as calculated after implementation of clinical guidelines for the management of hypercholesterolemia in a randomized, clinical trial

      CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
    90. de Sotomayor, MA; Herrera, MD; Marhuenda, E; Andriantsitohaina, R
      Characterization of endothelial factors involved in the vasodilatory effect of simvastatin in aorta and small mesenteric artery of the rat

      BRITISH JOURNAL OF PHARMACOLOGY
    91. Ugawa, T; Kakuta, H; Moritani, H; Matsuda, K; Ishihara, T; Yamaguchi, M; Naganuma, S; Iizumi, Y; Shikama, H
      YM-53601, a novel squalene synthase inhibitor, reduces plasma cholesterol and triglyceride levels in several animal species

      BRITISH JOURNAL OF PHARMACOLOGY
    92. Kumano, T; Mutoh, T; Nakagawa, H; Kuriyama, M
      HMG-CoA reductase inhibitor induces a transient activation of high affinity nerve growth factor receptor, Trk, and morphological differentiation withfatal outcome in PC12 cells

      BRAIN RESEARCH
    93. Suzuki, H; Yamazaki, H; Aoki, T; Kojima, J; Tamaki, T; Sato, F; Kitahara, M; Saito, Y
      Lipid-lowering and antiatherosclerotic effect of NK-104, a potent 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in Watanabe heritable hyperlipidemic rabbits

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    94. Mascaro, C; Ortiz, JA; Ramos, MM; Haro, D; Hegardt, FG
      Sterol regulatory element binding protein-mediated effect of fluvastatin on cytosolic 3-hydroxy-3-methylglutaryl-coenzyme A synthase transcription

      ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
    95. Wierzbicki, AS; Lumb, PJ; Chik, G; Crook, MA
      High-density lipoprotein cholesterol and triglyceride response with simvastatin versus atorvastatin in familial hypercholesterolemia

      AMERICAN JOURNAL OF CARDIOLOGY
    96. Stein, E; Plotkin, D; Bays, H; Davidson, M; Dujovne, C; Korenman, S; Stepanavage, M; Mercuri, M
      Effects of simvastatin (40 and 80 mg/day) in patients with mixed hyperlipidemia

      AMERICAN JOURNAL OF CARDIOLOGY
    97. Tolman, KG
      Defining patient risks fram expanded preventive therapies

      AMERICAN JOURNAL OF CARDIOLOGY
    98. Cullen, P; von Eckardstein, A; Souris, S; Schulte, H; Assmann, G
      Dyslipidaemia and cardiovascular risk in diabetes

      DIABETES OBESITY & METABOLISM
    99. Wierzbicki, AS; Lumb, PJ; Semra, Y; Chik, G; Christ, ER; Crook, MA
      Atorvastatin compared with simvastatin-based therapies in the management of severe familiar hyperlipidaemias

      QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS
    100. Wierzbicki, AS; Lumb, PJ; Chik, G; Crook, MA
      Comparison of therapy with simvastatin 80 mg and atorvastatin 80 mg in patients with familial hypercholesterolaemia

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/05/20 alle ore 12:23:45